Processa Pharmaceuticals Inc (PCSA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.20M
Last updated: Nov 17, 2026 at 11:00 AM ET
Processa Pharmaceuticals Inc (PCSA) Earnings: Report Dates and Results
Processa Pharmaceuticals (PCSA) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Processa Pharmaceuticals reported EPS of -$61.58. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
PCSA has an expected report date of Mar 16, 2027.
Earnings History
Of the 21 quarters below that had an estimate, PCSA beat 8 and missed 13. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 382.86% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$61.58 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2026 |
| Jun 30, 2026 | -$1.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2026 |
| Sep 30, 2025 | -$1.75 | -$2.00 | -$2.00 - -$2.00 | +12.50% | Beat | N/A | 1 | 1 up, 0 down | Nov 6, 2025 |
| Jun 30, 2025 | -$0.25 | -$0.23 | -$0.23 - -$0.23 | -8.70% | Miss | N/A | 1 | 0 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$7.50 | -$19.25 | -$19.25 - -$19.25 | +61.04% | Beat | N/A | 1 | 0 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$0.74 | -$0.92 | -$0.92 - -$0.92 | +19.57% | Beat | N/A | 1 | 0 up, 1 down | Mar 20, 2025 |
| Sep 30, 2024 | -$25.75 | -$25.00 | -$25.00 - -$25.00 | -3.00% | Miss | N/A | 1 | 0 up, 0 down | Oct 30, 2024 |
| Jun 30, 2024 | -$25.25 | -$24.50 | -$24.50 - -$24.50 | -3.06% | Miss | N/A | 1 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$27.75 | -$29.50 | -$29.50 - -$29.50 | +5.93% | Beat | N/A | 1 | 0 up, 0 down | May 10, 2024 |
| Dec 31, 2023 | -$1.70 | -$1.60 | -$1.60 - -$1.60 | -6.25% | Miss | N/A | 2 | 0 up, 0 down | Mar 29, 2024 |
| Sep 30, 2023 | -$40.00 | -$50.00 | -$50.00 - -$50.00 | +20.00% | Beat | N/A | 1 | 0 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$50.00 | -$75.00 | N/A | +33.33% | Beat | N/A | N/A | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$0.18 | -$0.28 | -$0.28 - -$0.28 | +35.71% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$175.00 | -$152.50 | -$180.00 - -$125.00 | -14.75% | Miss | N/A | 3 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$185.00 | -$167.50 | -$170.00 - -$165.00 | -10.45% | Miss | N/A | 3 | 0 up, 0 down | Nov 8, 2022 |
| Jun 30, 2022 | -$160.00 | -$95.00 | -$105.00 - -$95.00 | -68.42% | Miss | N/A | 3 | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$100.00 | -$106.67 | -$120.00 - -$100.00 | +6.25% | Beat | N/A | 4 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.21 | -$0.19 | -$0.20 - -$0.18 | -10.53% | Miss | N/A | 3 | N/A | Mar 30, 2022 |
| Sep 30, 2021 | -$95.00 | -$92.50 | -$105.00 - -$80.00 | -2.70% | Miss | N/A | 3 | 0 up, 0 down | Nov 12, 2021 |
| Jun 30, 2021 | -$100.00 | -$70.00 | -$75.00 - -$65.00 | -42.86% | Miss | N/A | 3 | N/A | Aug 12, 2021 |
| Mar 31, 2021 | -$70.00 | -$55.00 | -$55.00 - -$50.00 | -27.27% | Miss | N/A | 2 | N/A | May 13, 2021 |
| Dec 31, 2020 | -$1.69 | -$0.35 | -$0.55 - -$0.16 | -382.86% | Miss | N/A | 2 | N/A | Mar 25, 2021 |
| Sep 30, 2020 | -$99.75 | -$80.00 | -$80.00 - -$80.00 | -24.69% | Miss | N/A | 1 | N/A | Nov 12, 2020 |
| Jun 30, 2020 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 5, 2020 |
| Mar 31, 2020 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2020 |
| Dec 31, 2019 | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 6, 2020 |
| Sep 30, 2019 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 |
| Jun 30, 2019 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2019 |
| Mar 31, 2019 | -$2.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2019 |
| Dec 31, 2018 | -$2.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 28, 2019 |
| Sep 30, 2018 | -$3.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2018 |
| Jun 30, 2018 | -$4.61 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2018 |
| Mar 31, 2018 | -$4.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 16, 2018 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$79.49, after -$91.88 the year before. It was -$14.26 for the year ended Dec 31, 2018, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$79.49 | N/A |
| Dec 31, 2023 | -$91.88 | N/A |
| Dec 31, 2022 | -$620.00 | N/A |
| Dec 31, 2021 | -$265.21 | N/A |
| Dec 31, 2020 | -$101.73 | N/A |
| Dec 31, 2019 | -$3.29 | N/A |
| Dec 31, 2018 | -$14.26 | N/A |
Frequently Asked Questions About PCSA
When is Processa Pharmaceuticals's next earnings date?
Processa Pharmaceuticals's next earnings report is expected for Mar 16, 2027.
How often does PCSA beat earnings estimates?
Processa Pharmaceuticals beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +9.75%.
PCSA pages: Overview, Earnings, Financials, Competitors